Yahoo
NasdaqCM - Delayed Quote USD

BioCardia, Inc. (BCDA)

0.9302 +0.0048 (+0.52%)
At close: 4:00:00 PM EST
BCDA Q3 2026 earnings call
November 12, 2026 at 4:30 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-7,563 -7,436 -7,886 -9,974 -10,561
Cash Flow from Investing Activities
-9 -7 -6 -12 -70
Cash Flow from Financing Activities
10,709 7,568 9,160 3,726 5,122
Cash and Cash Equivalents, End of Period
4,117 2,496 2,371 1,103 7,363
Cash Flow, Supplemental
Free Cash Flow to Firm
-6,467 -7,300 -6,696 -10,115 -10,417
Capital Expenditure, Calculated
9 7 6 12 70
Issuance of Capital Stock
12,092 8,690 10,552 4,388 5,540
Repurchase of Capital Stock
-1,230 -930 -1,252 -662 -418
12/31/2022 - 11/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: